Medici Medical Ltd.

Medici

  • Boiron
  • Grifols
  • Sanofi Pasteur
  • BioClin
  • Contact
  • About
  • Sanofi Pasteur
  • Grifols
  • Boiron
  • BioClin
  • About
  • Products
  • 1
  • 1

IVIG ג€“ FLEBOGAMMA 5% DIF

 

Active ingredient: immunoglobulin normal humanֲ  -ֲ  0.5G/10ML

Shelf life presentation Packaging material
24 months 10 ML / 0.5g Vial glass type II
24 months 50 ML ֲ / 2.5g Bottle glass type II
24 months 100 ML / 5g Bottle glass type II
24 months 200 ML / 10g Bottle glass type II
24 months 400 ML / 20g Bottle glass type II

Replacement therapy in:

Primary immunodeficiency syndroms such as:

Congenital agammaglobulinaemia and hypogammaglobulinaemia

Common variable immunodeficiency

Severe combined immunodeficiency

Wiskott Aldrich syndrome

Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.

Children with congenital AIDS and recurrent infections.

Immunomodulation:

Idiopathic thrombocytopenicpurpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.

Guillain Barre’ Syndrome.

Kawasaki disease.

Allogeneic bone marrow transplantation.

 

 

IVIG stands for intravenous immune globulin; it is a sterile solution of concentrated antibodies extracted from healthy donors which is administered into a vein. IVIG is used to treat disorders of the immune system or to boost immune response to serious illness, and to treat immuno-suppressed recipients of bone marrow transplants.ֲ Antibodies are responsible for defending our bodies from pathogens, such as viruses and bacteria.

There is a highly specialized and lengthy process used to manufacture IVIG. It begins in blood centers across the country where tens of thousands of healthy individuals donate their plasma (the portion of the blood where the immune globulins and other blood proteins are contained). The plasma from all of these individuals is then pooled together, and then chemically treated to isolate the immune globulins and remove any other blood proteins or blood-borne pathogens. The end result is a highly purified immune globulin preparation that is then packaged and ready to be infused.

 

For more information :

http://grifols.com/en/web/spain/bioscience/-/product/flebogamma_5_dif

  • About
  • Products
  • 1
  • 1

Notice: Array to string conversion in /home/medici/public_html/wp-content/themes/medici/single.php on line 54